FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4701911000001101: Irinotecan hydrochloride trihydrate (substance)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2017. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    14721501000001116 Irinotecan hydrochloride trihydrate (substance) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
    14721601000001117 Irinotecan hydrochloride trihydrate en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Irinotecan hydrochloride trihydrate Is a Irinotecan false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 2mL vial Has active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 5mL vial Has active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Campto 100mg/5ml solution for injection vials (Pfizer Ltd) Has active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Campto 40mg/2ml solution for injection vials (Pfizer Ltd) Has active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 100mg/5ml solution for injection vials 1 vial Has active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 40mg/2ml solution for injection vials 1 vial Has active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Campto 100mg/5ml solution for injection vials (Pfizer Ltd) 1 vial Has active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Campto 40mg/2ml solution for injection vials (Pfizer Ltd) 1 vial Has active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 300mg/15ml solution for infusion vials Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Campto 300mg/15ml concentrate for solution for infusion vials (Pfizer Ltd) 1 vial Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Campto 300mg/15ml concentrate for solution for infusion vials (Pfizer Ltd) Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 300mg/15ml solution for infusion vials 1 vial Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 2mL vial Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Campto 40mg/2ml solution for injection vials (Pfizer Ltd) 1 vial Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Campto 40mg/2ml solution for injection vials (Pfizer Ltd) Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 40mg/2ml solution for injection vials 1 vial Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Campto 100mg/5ml solution for injection vials (Pfizer Ltd) 1 vial Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan hydrochloride trihydrate 20mg/mL infusion concentrate 5mL vial Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 100mg/5ml solution for injection vials 1 vial Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Campto 100mg/5ml solution for injection vials (Pfizer Ltd) Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 40mg/2ml concentrate for solution for infusion vials (Actavis UK Ltd) Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 100mg/5ml concentrate for solution for infusion vials (Actavis UK Ltd) Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 40mg/2ml concentrate for solution for infusion vials (Actavis UK Ltd) 1 vial Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 100mg/5ml concentrate for solution for infusion vials (Actavis UK Ltd) 1 vial Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 40mg/2ml concentrate for solution for infusion vials (Teva UK Ltd) Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 100mg/5ml concentrate for solution for infusion vials (Teva UK Ltd) Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 40mg/2ml concentrate for solution for infusion vials (Teva UK Ltd) 1 vial Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 100mg/5ml concentrate for solution for infusion vials (Teva UK Ltd) 1 vial Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 500mg/25ml solution for infusion vials Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 40mg/2ml concentrate for solution for infusion vials (A A H Pharmaceuticals Ltd) Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 100mg/5ml concentrate for solution for infusion vials (A A H Pharmaceuticals Ltd) Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 500mg/25ml concentrate for solution for infusion vials (Actavis UK Ltd) Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 500mg/25ml solution for infusion vials 1 vial Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 40mg/2ml concentrate for solution for infusion vials (A A H Pharmaceuticals Ltd) 1 vial Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 100mg/5ml concentrate for solution for infusion vials (A A H Pharmaceuticals Ltd) 1 vial Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 500mg/25ml concentrate for solution for infusion vials (Actavis UK Ltd) 1 vial Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 500mg/25ml concentrate for solution for infusion vials (A A H Pharmaceuticals Ltd) Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 500mg/25ml concentrate for solution for infusion vials (A A H Pharmaceuticals Ltd) 1 vial Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 100mg/5ml concentrate for solution for infusion vials (Viatris UK Healthcare Ltd) Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 40mg/2ml concentrate for solution for infusion vials (Viatris UK Healthcare Ltd) Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 40mg/2ml concentrate for solution for infusion vials (medac UK) Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 100mg/5ml concentrate for solution for infusion vials (medac UK) Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 300mg/15ml concentrate for solution for infusion vials (medac UK) Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 100mg/5ml concentrate for solution for infusion vials (Viatris UK Healthcare Ltd) 1 vial Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 40mg/2ml concentrate for solution for infusion vials (Viatris UK Healthcare Ltd) 1 vial Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 40mg/2ml concentrate for solution for infusion vials (medac UK) 1 vial Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 100mg/5ml concentrate for solution for infusion vials (medac UK) 1 vial Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 300mg/15ml concentrate for solution for infusion vials (medac UK) 1 vial Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 40mg/2ml concentrate for solution for infusion vials (Hospira UK Ltd) Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 100mg/5ml concentrate for solution for infusion vials (Hospira UK Ltd) Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 500mg/25ml concentrate for solution for infusion vials (Hospira UK Ltd) Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 40mg/2ml concentrate for solution for infusion vials (Hospira UK Ltd) 1 vial Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 100mg/5ml concentrate for solution for infusion vials (Hospira UK Ltd) 1 vial Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 500mg/25ml concentrate for solution for infusion vials (Hospira UK Ltd) 1 vial Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 300mg/15ml concentrate for solution for infusion vials (A A H Pharmaceuticals Ltd) Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 300mg/15ml concentrate for solution for infusion vials (A A H Pharmaceuticals Ltd) 1 vial Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 300mg/15ml concentrate for solution for infusion vials (Actavis UK Ltd) Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 300mg/15ml concentrate for solution for infusion vials (Actavis UK Ltd) 1 vial Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 40mg/2ml concentrate for solution for infusion vial (Accord Healthcare Ltd) (product) Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 100mg/5ml concentrate for solution for infusion vial (Accord Healthcare Ltd) (product) Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 500mg/25ml concentrate for solution for infusion vials (Accord Healthcare Ltd) Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 40mg/2ml concentrate for solution for infusion vial (Accord Healthcare Ltd) 1 vial (product) Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 100mg/5ml concentrate for solution for infusion vial (Accord Healthcare Ltd) 1 vial (product) Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 500mg/25ml concentrate for solution for infusion vials (Accord Healthcare Ltd) 1 vial Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 300mg/15ml concentrate for solution for infusion vial (Accord Healthcare Ltd) (product) Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan 300mg/15ml concentrate for solution for infusion vial (Accord Healthcare Ltd) 1 vial (product) Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Onivyde pegylated liposomal 43mg/10ml concentrate for dispersion for infusion vials (Servier Laboratories Ltd) Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials 1 vial Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier
    Onivyde pegylated liposomal 43mg/10ml concentrate for dispersion for infusion vials (Servier Laboratories Ltd) 1 vial Has specific active ingredient False Irinotecan hydrochloride trihydrate Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start